Loading...
Hang Lung Group Limited
HNLGY•PNK
Real Estate
Real Estate - Diversified
$9.10
$0.00(0.00%)
Hang Lung Group Limited (HNLGY) Financial Performance & Income Statement Overview
Review Hang Lung Group Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.83%
↑ 6.83%
Operating Income Growth
-14.92%
↓ 14.92%
Net Income Growth
-42.62%
↓ 42.62%
Operating Cash Flow Growth
29.66%
↑ 29.66%
Operating Margin
57.51%
↑ 57.51%
Gross Margin
63.24%
↑ 63.24%
Net Profit Margin
17.00%
↑ 17.00%
ROE
2.11%
↑ 2.11%
ROIC
3.16%
↑ 3.16%
Hang Lung Group Limited (HNLGY) Income Statement & Financial Overview
Review Hang Lung Group Limited's (HNLGY) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $5.38B | $6.51B | $5.35B | $5.53B |
Cost of Revenue | $2.17B | $2.77B | $1.60B | $1.49B |
Gross Profit | $3.21B | $3.75B | $3.76B | $4.03B |
Gross Profit Ratio | $0.60 | $0.58 | $0.70 | $0.73 |
R&D Expenses | $0.00 | $0.00 | $52.00M | $50.00M |
SG&A Expenses | $326.00M | $346.00M | $341.00M | $339.00M |
Operating Expenses | $326.00M | $3.86B | $2.29B | $1.62B |
Total Costs & Expenses | -$2.49B | $3.86B | $1.94B | $1.83B |
Interest Income | $20.00M | $40.00M | $52.00M | $50.00M |
Interest Expense | $0.00 | $0.00 | $1.09B | $897.00M |
Depreciation & Amortization | $71.00M | -$3.41B | $42.00M | $46.00M |
EBITDA | $2.96B | -$1.76B | $3.46B | $3.74B |
EBITDA Ratio | $0.55 | -$0.27 | $0.65 | $0.68 |
Operating Income | $2.89B | $3.41B | $3.42B | $3.69B |
Operating Income Ratio | $0.54 | $0.52 | $0.64 | $0.67 |
Other Income/Expenses (Net) | -$944.00M | -$1.26B | -$656.00M | -$8.00M |
Income Before Tax | $1.95B | $2.15B | $2.76B | $3.69B |
Income Before Tax Ratio | $0.36 | $0.33 | $0.52 | $0.67 |
Income Tax Expense | $660.00M | $756.00M | $812.00M | $847.00M |
Net Income | $725.00M | $888.00M | $1.13B | $1.68B |
Net Income Ratio | $0.13 | $0.14 | $0.21 | $0.30 |
EPS | $0.53 | $0.65 | $0.83 | $1.24 |
Diluted EPS | $0.53 | $0.65 | $0.83 | $1.24 |
Weighted Avg Shares Outstanding | $1.36B | $1.37B | $1.36B | $1.36B |
Weighted Avg Shares Outstanding (Diluted) | $1.36B | $1.36B | $1.36B | $1.36B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan